Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | FPR3 | P25089 | 1/20 | 0.32 |
| ▸ | FPR2 | P25090 | 1/20 | 0.32 |
| ▸ | CDK4 | P11802 | 1/20 | 0.32 |
| ▸ | CCND1 | P24385 | 1/20 | 0.32 |
| ▸ | CCND2 | P30279 | 1/20 | 0.32 |
| ▸ | CCND3 | P30281 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6861363 | 0.84 | SMN1; SMN2 (0.42) | KDM4EALDH1A1HSD17B10TP53CYP3A4 | |
| SCHEMBL6016946 | 0.83 | SMN1; SMN2 (0.44) | KDM4EALDH1A1HSD17B10TP53CYP3A4 | |
| SCHEMBL5553557 | 0.81 | SMN1; SMN2 (0.37) | KDM4EALDH1A1HSD17B10TP53CYP3A4 | |
| SCHEMBL6231918 | 0.75 | DRD2 (0.39) | TSHRDRD2 | |
| SCHEMBL6238830 | 0.75 | SMN1; SMN2 (0.43) | ALDH1A1TSHRSMN1; SMN2DRD2 | |
| SCHEMBL5036468 | 0.74 | TSHR (0.36) | KDM4EALDH1A1HSD17B10TP53CYP3A4 | |
| SCHEMBL6235105 | 0.73 | SMN1; SMN2 (0.34) | TSHRSMN1; SMN2DRD2 | |
| SCHEMBL5554556 | 0.73 | PIM1 (0.42) | KDM4EALDH1A1HSD17B10TP53CYP3A4 | |
| SCHEMBL6607362 | 0.72 | GALR1 (0.39) | TSHRDRD2 | |
| SCHEMBL6235512 | 0.71 | SMN1; SMN2 (0.42) | KDM4EALDH1A1HSD17B10TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040077648-A1 | Methods and compositions of novel triazine compounds | DR. REDDY'S LABORATORIES LTD. (IN) | 2004-04-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077648-A1 | Methods and compositions of novel triazine compounds | AREG, TGFB1, PTGIS | KDM4E 3314/4885ALDH1A1 4407/4885HSD17B10 1873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.